|
"高嘉宏"的相关文件
显示项目 91-140 / 491 (共10页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2016 |
How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?
|
Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Hung-Chih; Chen, Chi-Ling; Yang, Wan-Ting; Tsai, Cheng-Shiue; Kuo, Stephanie Fang-Tzu; Verbree, Femke Carolien; Su, Tung-Hung; Wang, Chia-Chi; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2015 |
HBV cure-can we pin our hopes on immunotherapy?
|
Yang, Hung-Chih; Kao, Jia-Horng; 高嘉宏; 楊宏志 |
| 國立臺灣大學 |
2015 |
Advanced Hepatic Fibrosis and Steatosis Are Associated With Persistent Alanine Aminotransferase Elevation in Chronic Hepatitis C Patients Negative for Hepatitis C Virus RNA During Pegylated Interferon Plus Ribavirin Therapy
|
Liang, Cheng-Chao; Liu, Chen-Hua; Chung, Chen-Shuan; Lin, Cheng-Kuan; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
New Insights into the Evolutionary Rate of Hepatitis B Virus at Different Biological Scales
|
Lin, You-Yu; Liu, Chieh; Chien, Wei-Hung; Wu, Li-Ling; Tao, Yong; Wu, Dafei; Lu, Xuemei; Hsieh, Chia-Hung; Chen, Pei-Jer; Wang, Hurng-Yi; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 高嘉宏; 陳培哲; 王弘毅 |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
|
Tseng, T. -C.; Liu, C. -J.; Chen, C. -L.; Yang, W. -T.; Yang, H. -C.; Su, T. -H.; Wang, C. -C.; Kuo, S. F. -T.; Liu, C. -H.; Chen, P. -J.; Chen, D. -S.; Kao, J. -H.; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Distinct viral evolution and quasispecies dynamics between hepatitis B e antigen seroconverters and non-seroconverters in response to interferon-based therapy
|
Yang, Hung-Chih; Lin, Su-Ru; Liu, Chun-Jen; Peng, Cheng-Yuan; Tseng, Tai-Chung; Su, Tung-Hung; Chen, Pei-Jer; Kao, Jia-Horng; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Serum viral load is not the major determinant of hepatocellular carcinoma risk in chronic hepatitis B patients with compensated liver cirrhosis
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Yang, Hung-Chih; Chen, Chi-Ling; Su, Tung-Hung; Kao, Jia-Horng; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu, Chen-Hua; Sheng, Wang-Hui; Sun, Hsin-Yun; Hsieh, Szu-Min; Lo, Yi-Chun; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Liu, Wen-Chun; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 孫幸筠; 劉俊人; 謝思民; 陳培哲; 盛望徽; 洪健清 |
| 國立臺灣大學 |
2015 |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, Tung-Hung; Shiau, Chung-Wai; Jao, Ping; Liu, Chen-Hua; Liu, Chun-Jen; Tai, Wei-Tien; Jeng, Yung-Ming; Yang, Hung-Chih; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 陳昆鋒; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Treating Immune-tolerant Hepatitis B
|
Tseng, T-C; Kao, J-H; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Hepatitis B virus infection and metabolic syndrome: Fact or fiction?
|
Wang, Chia-Chi; Tseng, Tai-Chung; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study
|
Huang, Y. -W.; Wang, T. -C.; Yang, S. -S.; Lin, S. -Y.; Fu, S. -C.; Hu, J. -T.; Liu, C. -J.; Kao, J. -H.; Chen, D. -S.; 陳定信; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2015 |
On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy
|
Huang, Yi-Wen; Takahashi, Shoichi; Tsuge, Masataka; Chen, Chi-Ling; Wang, Ting-Chuan; Abe, Hiromi; Hu, Jui-Ting; Chen, Ding-Shinn; Yang, Sien-Sing; Chayama, Kazuaki; Kao, Jia-Horng; 陳定信; 高嘉宏; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Improving clinical outcomes of chronic hepatitis B virus infection
|
Su, Tung-Hung; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2015 |
Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection
|
Hsu, Ching-Sheng; Liu, Wei-Liang; Chao, You-Chen; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Hepatitis B Virus Genotypes and Variants
|
Lin, Chih-Lin; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
What can we learn from hepatitis B virus clinical cohorts?
|
Lin, Chih-Lin; Tseng, Tai-Chung; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages
|
Liu, Chun-Jen; Chen, Ting-Chih; Chen, Pei-Jer; Wang, Hurng-Yi; Tseng, Tai-Chung; Cheng, Huei-Ru; Liu, Chen-Hua; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 王弘毅 |
| 國立臺灣大學 |
2015 |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System
|
Liu, Jessica; Tseng, Tai-Chung; Yang, Hwai-I; Lee, Mei-Hsuan; Batrla-Utermann, Richard; Jen, Chin-Lan; Lu, Sheng-Nan; Wang, Li-Yu; You, San-Lin; Chen, Pei-Jer; Chen, Chien-Jen; Kao, Jia-Horng; 陳建仁; 高嘉宏; 陳培哲 |
| 國立臺灣大學 |
2015 |
Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure
|
Zeisel, Mirjam B.; Lucifora, Julie; Mason, William S.; Sureau, Camille; Beck, Juergen; Levrero, Massimo; Kann, Michael; Knolle, Percy A.; Benkirane, Monsef; Durantel, David; Michel, Marie-Louise; Autran, Brigitte; Cosset, Francois-Loic; Strick-Marchand, Helene; Trepo, Christian; Kao, Jia-Horng; Carrat, Fabrice; Lacombe, Karine; Schinazi, Raymond F.; Barre-Sinoussi, Francoise; Delfraissy, Jean-Francois; Zoulim, Fabien; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma
|
Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan
|
Chen, Chi-Ling; Yang, Jyh-Yuan; Lin, Szu-Fong; Sun, Chien-An; Bai, Chyi-Huey; You, San-Lin; Chen, Chien-Jen; Kao, Jia-Horng; Chen, Pei-Jer; Chen, Ding-Shinn; 陳定信; 陳建仁; 高嘉宏; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Asian Patients with Genotype 1 HCV Infection Achieve 99% Sustained Virologic Response with 12 Weeks of Ledipasvir/Sofosbuvir Single Tablet Regimen: Integrated analysis of Phase 3 Multicenter Studies
|
Mizokami, Masashi; Chuang, Wan-Long; Han, Kwang-Hyub; Lim, Young-Suk; Yang, Jenny C.; De-Oertel, Shampa; Gao, Bing; Mo, Hongmei; Pang, Phillip S.; Knox, Steven J.; McHutchison, John G.; Omata, Masao; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients
|
Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Wu, Hui-Lin; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Can Noninvasive Biomarkers Replace Liver Biopsy for Chronic Hepatitis B?
|
Lin, Chih-Lin; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Asian Patients with Chronic Genotype 2 HCV Infection Achieve 98% Sustained Virologic Response Following 12 Week administration of Sofosbuvir in Combination with Ribavirin: Integrated analysis of Phase 3 Multicenter Studies
|
Omata, Masao; Lim, Young-Suk; Chuang, Wan-Long; Kao, Jia-Horng; Gao, Bing; De-Oertel, Shampa; Yang, Jenny C.; Mo, Hongmei; Brainard, Diana M.; Knox, Steven J.; McHutchison, John G.; Mizokami, Masashi; Han, Kwang-Hyub; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Perspectives and control of hepatitis B virus infection in Taiwan
|
Lin, Chih-Lin; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang, Chia-Chi; Liu, Chen-Hua; Lin, Chih-Lin; Wang, Pin-Chao; Tseng, Tai-Chung; Lin, Hans Hsienhong; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Hepatitis B vaccination and prevention of hepatocellular carcinoma
|
Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
|
Hsu, Ching-Sheng; Chao, You-Chen; Lin, Hans Hsienhong; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
|
Lin, Chih-Lin; Liu, Chen-Hua; Wang, Chia-Chi; Liang, Cheng-Chao; Su, Tung-Hung; Liu, Chun-Jen; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2015 |
The NIACE score helps predict the survival of Asian hepatocellular carcinoma patients
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Adhoute, Xavier; Bourliere, Marc; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir
|
Chen, Guei-Ying; Su, Tung-Hung; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2015 |
Benefits of Antiviral Treatment and Predictors of Subsequent Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with or without Sustained Virological Response to Peg-interferon plus Ribavirin Therapy
|
Lee, Mei-Hsuan; Lu, Sheng-Nan; Yu, Ming-Lung; Peng, Cheng-Yuan; Sheen, I-Shyan; Liu, Chen-Hua; Kao, Jia-Horng; Chuang, Wan-Long; Yang, Hwai-I; L'Italien, Gilbert; Yuan, Yong; Chen, Chien-Jen; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients
|
Huang, Yi-Wen; Yang, Sien-Sing; Kao, Jia-Horng; 高嘉宏 |
| 國立交通大學 |
2014-12-12T01:44:12Z |
輿論溝通對爭議性技術/觀念之擴散動態與過程的影響及交互作用
|
高嘉宏; Kao, Chia-Hung; 孫春在; Sun, Chuen-Tsai |
| 國立臺灣大學 |
2014 |
Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
|
Yang, Hung-Chih; Kao, Jia-Horng; 高嘉宏; 楊宏志 |
| 國立臺灣大學 |
2014 |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Jeng, Yung-Ming; Cheng, Huei-Ru; Liu, Chen-Hua; Tseng, Tai-Chung; Ling, Thai-Yen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 林泰元; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2014 |
Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2014 |
THE CRISPR/Cas9 SYSTEM FACILITATES ELIMINATION OF THE PERSISTENT INTRAHEPATIC HBV GENOMES IN VIVO
|
Yang, H. -C.; Lin, S. -R.; Liu, C. -J.; Kao, J. -H.; Chen, D. -S.; Chen, P. -J.; 陳定信; 高嘉宏; 楊宏志; 劉俊人; 陳培哲 |
显示项目 91-140 / 491 (共10页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
